Adele Gulfo

Adele Gulfo is a recognized leader in healthcare, currently serving as a board director and life science/biopharma advisor. They have held prominent positions, including Chief Executive Officer of Biopharma Commercial at Sumitomo Pharma America and President and General Manager of Pfizer’s U.S. Primary Care business, where they significantly contributed to the launch of several blockbuster brands. With a robust educational background that includes an MBA and a degree in Biology and Chemistry, Adele has also been involved with various organizations such as the Committee of 200 and multiple corporate boards, including NewAmsterdam Pharma Corporation and Battelle. They have received recognition for developing impactful medical and public-education campaigns in cardiovascular health and hold five patents.